Wound Management Market 2008-2017

Worldwide Wound Management, Forecast to 2017:
Established and Emerging Products, Technologies and Markets
in the U.S., Europe, Japan and Rest of World

· 266 pages · 59 Exhibits · 71 Company Profiles · Report #S247 · Published September 2009

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

The report provides full year (actual) 2008 market size and share data, with forecast market data to 2017, for the U.S., Europe, Asia/Pacific and Rest of World.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with data on products, technologies and positions in the advanced wound care market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents

Methodology

Download the report now
by purchasing online

or fax us your order form

Single user
price $2,850

EXECUTIVE SUMMARY

Acute Wounds

Burns

Chronic Wounds

Products Used in Advanced Wound Management

Film Dressings

Hydrocolloid Dressings

Foam Dressings

Alginate Dressings

Hydrogels

Non-Adherent Dressings

Anti-Microbial Dressings

Wound Cleansers and Debriding Agents

Skin Replacements and Substitutes

Pharmacological Products

Physical Therapies

The Market

The Industry

SECTION 1: BACKGROUND

1.1 Industry Structure

1.2 A Complex Industry

1.3 Major Wound Management Corporations

1.4 Historical Perspective and Technology Breakthroughs

1.5 Worldwide Regulatory and Reimbursement Environment

1.5.1 Cost Effectiveness

1.5.2 Clinical

1.5.3 Regulatory

1.5.4 Reimbursement

1.5.4.1 U.S.A

1.5.4.2 European Union

1.5.4.3 France

1.5.4.4 Germany

1.5.4.5 United Kingdom .

1.5.4.6 Italy

1.5.4.7 Belgium

1.5.4.8 Spain

1.5.4.9 Scandinavia.

1.6 Geographical Differences in Treatments of Wounds

1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence

1.8 Wound Management Trends

1.8.1 Surgical Wounds

1.8.2 Traumatic Wounds

1.8.3 Burns

1.8.4 Chronic Wounds

1.9 Market Dynamics

SECTION 2: CLINICAL BACKGROUND AND CASELOAD

2.1 Background

2.1.1 A Few Figures

2.1.2 Overview of Functions

2.1.3 Skin Anatomy: A Summary

2.2 Types of Wounds

2.2.1 Classification By Severity

2.2.2 Classification By Morphology

2.2.3 Classification By Etiology

2.2.4 Color Classification

2.3 Surgical Wounds

2.4 Traumatic Wounds

2.5 Burns

2.5.1 Debridement

2.5.2 Grafting

2.6 Pressure Ulcers

2.6.1 Ulcer Classification

2.6.2 Hospital-Acquired Ulcers

2.6.3 Management of Pressure Ulcers

2.7 Venous Ulcers

2.8 Arterial Ulcers

2.9 Diabetic Ulcers

2.9.1 Prevalence

2.9.2 Stages of Diabetic Ulcer

2.9.3 Treatment

2.9.3.1 Amputations

2.9.3.2 Abnormal Scarring

2.9.4 Acquired Immunodeficiency Syndrome

2.10 Wound Healing Physiology

2.10.1 Inflammatory Phase

2.10.2 Proliferative Phase

2.10.2.1 Angiogenesis

2.10.3 Maturation Phase

2.11 Factors Affecting Wound Healing

2.11.1 Extrinsic Factors

2.11.2 Mechanical Stress

2.11.3 Debris

2.11.4 Temperature

2.11.5 Desiccation and Maceration

2.11.6 Infection

2.11.7 Chemical Stress

2.11.8 Medication

2.11.9 Other Extrinsic Factors

2.11.10 Intrinsic Factors

2.11.11 Health Status

2.11.12 Age Factors

2.11.13 Body Build

2.11.14 Nutritional Status

2.12 Major Treatment Categories and Regimes

2.13 Incidence of Treatments, Growth Rates and Trends

SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS

3.1 Background

3.2 Film Dressings

3.2.1 Overview

3.2.2 Product Examples

3.2.3 Market and Competitive Activity

3.3 Hydrocolloids

3.3.1 Overview

3.3.2 Product Examples

3.3.3 Market and Competitive Activity

3.4 Foam Dressings

3.4.1 Overview

3.4.2 Product Examples

3.4.3 Market and Competitive Activity

3.5 Alginate Dressings

3.5.1 Overview

3.5.2 Product Examples

3.5.3 Market and Competitive Activity

3.6 Hydrogels

3.6.1 Overview

3.6.2 Product Examples

3.6.3 Market and Competitive Activity

3.7 Non-Adherent Dressings

3.7.1 Overview

3.7.2 Product Examples

3.7.3 Market and Competitive Activity

3.8 Antimicrobial Dressings

3.8.1 Overview

3.8.2 Product Examples

3.8.3 Market and Competitive Activity

3.9 Tissue-Engineered Products

3.9.1 Overview

3.9.2 Traditional Skin Grafts

3.9.3 Skin Replacements

3.9.4 Product Examples

3.9.5 Market and Competitive Analysis

3.10 Pharmacological Products

3.10.1 Overview

3.10.2 Product Examples

3.10.2.1 Growth Factors

3.10.2.2 Growth Factors: Background.

3.10.2.3 Classification

3.10.2.4 Other Growth Factors

3.10.2.5 Non-Growth Factor Modulators

3.10.3 Market and Competitive Analysis

3.10.3.1 Growth Factors

3.10.3.2 Non-Growth Factor Stimulants

3.10.3.3 Gene Therapy

3.11 Physical Treatments

3.11.1 Negative Pressure Devices

3.11.2 Positive Pressure Devices

3.11.3 Mechanically Assisted Wound Closure

3.11.4 Other Physical Wound Therapies

3.11.4.1 Hydrotherapy

3.11.4.2 Electrical Stimulation

3.11.4.3 Electromagnetic Stimulation Devices

3.11.4.4 Ultraviolet Therapy

3.11.4.5 Hyperbaric Oxygen Therapy

3.11.4.6 Ultrasound Devices

3.11.4.7 Laser Devices

3.11.4.8 Wound Imaging/Documentation

3.11.5 Market and Competitive Analysis..

3.11.5.1 Pressure Relief Devices.

3.11.5.2 Hydrotherapy

3.11.5.3 Electrical Stimulation

3.11.5.4 Hyperbaric Oxygen Therapy

SECTION 4: COUNTRY MARKET ANALYSIS

4.1 Global Overview

4.2 Market Estimates

4.2.1 Market Potential

4.2.2 Leading Wound Care Companies

4.2.3 Leading National Markets

4.3 United States

4.3.1 Market Opportunity.

4.3.2 Market for Advanced Wound Management Products

4.4 Japan

4.4.1 Wound Care Market

4.4.2 Market Opportunity

4.4.3 Leading Companies

4.5 Germany

4.5.1 Wound Care Market

4.5.2 Leading Companies.

4.6 France

4.6.1 Wound Care Market

4.6.2 Leading Companies.

4.7 Italy

4.7.1 Wound Care Market

4.7.2 Leading Companies.

4.8 United Kingdom

4.8.1 Wound Care Market

4.8.2 Leading Companies

SECTION 5: COMPANY PROFILES

5.1 Major Companies

5.1.1 3M Health Care

5.1.2 B. Braun Melsungen AG

5.1.3 Coloplast Group

5.1.3.1 Financials

5.1.4 ConvaTec Inc.

5.1.5 Covidien

5.1.5.1 Kendall

5.1.6 Derma Sciences, Inc.

5.1.7 DeRoyal Industries Inc.

5.1.8 Ethicon (Johnson & Johnson)

5.1.9 Gentell Inc.

5.110 Geritrex Corp

5.1.11 Hartmann Group

5.1.12 Hollister Incorporated

5.1.13 Lohmann & Rauscher International GmbH and Co. KG

5.1.14 Medline Industries

5.1.15 Mölnlycke Health Care AB

5.1.16 Smith & Nephew plc

5.1.17 Systagenix Wound Management (US), Inc.

5.1.18 UDL Laboratories

5.2 Specialist Companies

5.2.1 Antimicrobial Dressings

5.2.1.1 AcryMed Inc.

5.2.1.2 Argentum Products LLC

5.2.1.3 Microban International Ltd

5.2.2 Oxygen Therapy

5.2.2.1 Perry Baromedical

5.2.3 Tissue Regeneration

5.2.3.1 Perry Baromedical

5.2.3.2 Celltran Limited

5.2.3.3 Euroderm AG

5.2.3.4 Fidia Advanced Biopolymers

5.2.3.5 Forticell Bioscience, Inc.

5.2.3.6 Genzyme Biosurgery

5.2.3.7 Integra LifeSciences Inc.

5.2.3.8 Organogenesis Inc.

5.2.3.9 Kinetic Concepts Inc.

5.2.3.9.1 LifeCell Corporation

5.2.4 Growth Factors

5.2.4.1 ES Cell International

5.2.5 Electrical Therapies

5.2.5.1 BioMedical Life Systems, Inc.

5.2.5.2 Diapulse Corporation of America

5.2.5.3 Electromedical Products International Inc.

5.2.5.4 Koldcare

5.2.5.5 Microvas Technologies

5.2.6 Odor Control

5.2.6.1 CliniMed

5.2.7 Other Therapeutic Modalities

5.2.7.1 AGT Sciences Ltd

5.2.7.2 Agennix

5.2.7.3 Advanced Medical Solutions Group plc

5.2.7.4 Anodyne Therapy LLC

5.2.7.5 Applied Tissue Technologies

5.2.7.6 Regenesis Biomedical Inc.

5.2.7.7 Roho Inc.

5.2.7.8 Uluru, Inc.

5.2.8 Summary Profiles

5.2.8.1 AciesHealth

5.2.8.2 Bard Medical Division

5.2.8.3 Brennen Medical Inc.

5.2.8.4 BSN medical Ltd

5.2.8.5 Celleration, Inc.

5.2.8.6 DermaRite Industries LLC

5.2.8.7 Ferris Manufacturing Corp.

5.2.8.8 Fibrogen

5.2.8.9 Geistlich Pharma.

5.2.8.10 Healthpoint

5.2.8.11 HemCon Medical Technologies

5.2.8.12 Human BioSciences, Inc.

5.2.8.13 Hymed Group Corporation

5.2.8.14 Innocol, Inc.

5.2.8.15 Laboratoires Urgo

5.2.8.16 LifeWave Ltd

5.2.8.17 Longport Inc.

5.2.8.18 MPM Medical

5.2.8.19 Nagor Ltd

5.2.8.20 Oculus Innovative Sciences, Inc.

5.2.8.21 Pioneer Surgical Technology, Inc.

5.2.8.22 Unomedical

5.2.8.23 Swiss American Products, Inc.

5.2.8.23.1 Wound Care Products

5.2.8.24 Wound Care Innovations, LLC

APPENDIX: LIST OF COMPANIES

List of Exhibits

Exhibit ES-1: Advanced Wound Care Market, by Segment, 2008 & 2017

Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2008

Exhibit 1-1: Worldwide Wound Prevalence by Etiology, 2008

Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2008–2017

Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2008–2017

Exhibit 2-1: Classification of Wounds by Etiology

Exhibit 2-2: Old and New Classification Systems for Burns

Exhibit 2-3: Distribution of Pressure Ulcers

Exhibit 3-1: Companies and Products in the Film Dressings Category

Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2008–2017

Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category

Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2008–2017

Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-7: Leading Companies and Products in the Foam Dressings Category

Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2008–2017

Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-10: Companies and Products in the Alginate Dressings Category

Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2008–2017

Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-13: Amorphous Hydrogels – Companies and Products

Exhibit 3-14: Impregnated Hydrogels – Companies and Products

Exhibit 3-15: Sheet Hydrogels, Companies and Products

Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2008–2017

Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category

Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2008–2017

Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-21: Companies and Products in the Antimicrobial Dressings Category

Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2008-2017

Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007, 2008

Exhibit 3-24: Companies and Products in the Tissue Engineering Category

Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2008–2017

Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007, 2008

Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2008–2017

Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category

Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2008–2017

Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2008–2017

Exhibit 4-2: Leading Global Wound Care Companies, Market Share, 2008

Exhibit 4-3: National Shares of the Global Advanced Wound Management Market, 2008

Exhibit 4-4: Forecast U.S. Sales for Advanced Wound Management Products, 2008–2017

Exhibit 4-5: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 4-6: Japanese Sales for Advanced Wound Management Products, 2008–2017

Exhibit 4-7: Japanese Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 4-8: German Sales for Advanced Wound Management Products, 2008–2017

Exhibit 4-9: German Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 4-10: French Sales for Advanced Wound Management Products, 2008–2017

Exhibit 4-11: French Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 4-12: Italian Sales for Advanced Wound Management Products, 2008–2016

Exhibit 4-13: Italian Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 4-14: UK Sales for Advanced Wound Management Products, 2008–2017

Exhibit 4-15: UK Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017

Exhibit 5-1: Coloplast Revenues by Business Area (DKK Millions)

Exhibit 5-2: Selected Johnson & Johnson Medical Devices and Diagnostics Companies

Exhibit 5-3: Leading Advanced Wound Management Products and Suppliers

Exhibit 5-4: Integra LifeSciences Financial Data, 2007, 2008 ($ Millions), Year Ending Dec. 31

Exhibit 5-5: Financial Data for Uluru, Fiscal Year 2007 and 2008

Exhibit 5-6: Oculus Innovative Sciences, FY Fourth Quarter 2008 vs. 2009 Data (Year-End March 31)

Worldwide Wound Management, Forecast to 2017: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan & Rest of World

Price: $2,850 (print or PDF; add $200 for both). Site/Global also available.